The development of personalized neoantigen peptide vaccines will specifically and effectively target cancer cells in individuals, opening a new door for cancer immunotherapy. Creative Biolabs has cGMP-certified production facilities and expertise that enable us to produce non-GMP and GMP grade peptides. Using state-of-the-art equipment and an experienced team with the latest technology, Creative Biolabs' comprehensive range of high-quality peptide synthesis services includes customized peptide synthesis, high-throughput peptide libraries, and peptide array services.
Creative Biolabs’ GMP manufacturing facilities are designed in strict accordance with the FDA's GMP manufacturing guidelines. We produce peptides up to 50 amino acids in length ranging from grams to kilograms. Our manufacturing capabilities are designed to meet the needs of our customers:
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE